As we previously highlighted the importance of the tumor glyco-code for immune responses in melanoma and its link with patient’s clinical outcome, we further explored whether the tumor glyco-code could be linked with the proportions of tumor-infiltrating immune cells (CD45 cells, DC subsets, T cells) in melanoma patients. Here, PTPRC is linked to melanoma.